Skip to main content
. 2014 May 15;171(11):2767–2777. doi: 10.1111/bph.12597

Figure 6.

Figure 6

The effect of the CB1 receptor antagonist SR141716 (A) and the CB2 receptor antagonist SR144528 (B) on inhibition of EFS-induced cholinergic contraction in human bronchi by 3 μM WIN55,212-2. Data are shown as mean ± SEM percentage inhibition of cholinergic contraction obtained with bronchi from three to six different patients.